News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Features Obesity and COVID-19: Theories and Blame Fill the Scientific Void Shelley Wood April 21, 2020
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Conference News ACC 2020 Evinacumab Cuts LDL Cholesterol in Homozygous FH Yael L. Maxwell April 01, 2020
News Daily News Coconut Oil Ups LDL Cholesterol Compared With Other Fats: Meta-analysis Yael L. Maxwell January 16, 2020
News Daily News Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart Michael O'Riordan January 07, 2020
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Most Supplements and Diets Don’t Lower CVD or Mortality Risks Michael O'Riordan July 09, 2019
News Daily News High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals Lucy Hicks August 21, 2018
News Daily News Global Burden of HIV-Related CVD Has Tripled Over Two Decades Lucy Hicks July 13, 2018
News Conference News ACC 2018 SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients Michael O'Riordan March 11, 2018
News Daily News Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events Michael O'Riordan December 07, 2017
News Industry News New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes September 15, 2017
News Daily News Many Stroke Patients Stop Statins or Never Start, With Dire Consequences Michael O'Riordan August 02, 2017
News Daily News Optimal Cardiovascular Health Not Offset by Poor Health as a Whole Ashley Lyles June 20, 2017
News Daily News $2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor Michael O'Riordan May 12, 2017